ArticleOncology letters2025

Evaluation of the efficacy of PD‑1/PD‑L1 inhibitor plus bevacizumab and chemotherapy for the treatment of patients with driver gene‑negative advanced‑stage lung adenocarcinoma: A retrospective cohort study.

Xiaozun Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.